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Long-term potentiation (LTP) is the key cellular mechanism for physiological learning and pathological chronic pain.
Postsynaptic accumulation of AMPA receptor (AMPAR) GluA1 plays an important role for injury-related cortical LTP.
However, there is no direct evidence for postsynaptic GluA1 insertion or accumulation after peripheral injury. Here
we report nerve injury increased the postsynaptic expression of AMPAR GluA1 in pyramidal neurons in the layer V
of the anterior cingulate cortex (ACC), including the corticospinal projecting neurons. Electrophysiological recordings
show that potentiation of postsynaptic responses was reversed by Ca2+ permeable AMPAR antagonist NASPM. Finally,
behavioral studies show that microinjection of NASPM into the ACC inhibited behavioral sensitization caused by nerve
injury. Our findings provide direct evidence that peripheral nerve injury induces postsynaptic GluA1 accumulation in
cingulate cortical neurons, and inhibits postsynaptic GluA1 accumulation which may serve as a novel target for treating
neuropathic pain.Introduction
Glutamate is the major excitatory transmitter in the cen-
tral nervous system, from the spinal cord to cortex [1,2].
Most of the postsynaptic currents are mediated by
AMPA receptors, while NMDA receptor and metabotro-
pic glutamate receptors mainly contribute to the induc-
tion and regulation of synaptic plasticity - including long
term potentiation (LTP) and long term depression (LTD)
[3-6]. Hippocampal synapses are mostly investigated as a
result of its important role in learning and memory. De-
pending on the induction protocols, recording methods
and central regions, there are two major forms of synap-
tic mechanisms - presynaptic enhancement of glutamate
release, and/or postsynaptic potentiation of AMPARs –
which contribute to hippocampal potentiation [3,4,6,7].
Recent studies in adult cortical areas indicate that simi-
lar LTP takes place in adult cortical excitatory synapses* Correspondence: deptanat@fmmu.edu.cn; minzhuo@utoronto.ca
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unless otherwise stated.[2,8,9]. Under pathological conditions such as periph-
eral chronic inflammation or nerve injury, excitatory
synaptic transmission in the ACC is potentiated for a
long term period of time [8-13]. Integrative experimen-
tal approaches including electrophysiological, pharma-
cological and biochemical methods demonstrate that
AMPA GluA1 receptors are required for injury induced
potentiation [11,14-17].
The subunits of AMPAR (GluA1-GluA4) are dynamic
at synaptic sites and their trafficking onto plasma mem-
brane plays an important role in synaptic potentiation
such as LTP [3,5,18]. However, previous evidence that
links postsynaptic AMPAR trafficking to behavioral
learning is mostly indirect in mammals. Evidence for
experience strengthened synaptic transmission in the
central synapses came from electrophysiological and
pharmacological experiments [19,20]. A recent study in
the snail sensory ganglia reported learning-induced
AMPAR trafficking [21]. To our knowledge, there is
no direct evidence for learning or experience driven
AMPAR trafficking at central synapses in behavioral
animals. In the present study, we demonstrate that nervetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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synaptic membranes of the ACC pyramidal neurons in
adult mice. Furthermore, we show that GluA1 accumu-
lation occurred exclusively in the corticospinal project-
ing cells, highlighting its important roles in sensory
modulation at the level of the spinal cord. Using GluA1
phosphorylation site knock-in mice, we find that protein
kinase A (PKA) phosphorylation of GluA1was critical
for the nerve injury induced potentiation and behavioral
sensitization. Finally, we show that application of Ca2+
permeable AMPAR antagonist NAPSM reduced LTP in
the ACC, as well as behavioral sensitization in freely
moving mice.
Results
Nerve injury causes long-term increases in postsynaptic
GluA1 subunits
AMPAR GluA1 subunit trafficking into the postsynaptic
region is believed to be important for synaptic potenti-
ation [22-26]. By applying whole-cell patch-clamp recor-
ding, we have confirmed that nerve injury potentiates
AMPAR mediated evoked EPSCs (eEPSCs) in the pyram-
idal cells in layer V of the ACC [15]. We wanted to check
whether the potentiated electrophysiological responses
were due to increased expression of postsynaptic GluA1.
SDS digested freeze-fracture replica labeling (SDS-FRL)Figure 1 Postsynaptic accumulation of GluA1 in the ACC after nerve
showing that increased GluA1 particles in the synaptic region on ACC laye
surgery. Bar equals to 200 nm. (C) Cumulative histograms showing the dist
postsynaptic GluA1. **, p <0.01.method was employed, in which the two-dimensional cell
membrane structure, as well as the distribution and dens-
ity of GluA1 could be examined at individual synapses of
the ACC layer V neurons [27]. The excitatory postsynaptic
area was identified with the clustering of intra-membrane
particles on the exoplasmic fracture face (E-face). In the
ACC layer V from both nerve injured and sham operated
mice, immunogold particles for GluA1 on the E-face were
detected in postsynaptic sites (Figure 1A-B). We found
that the distribution of synaptic GluA1 density from the
nerve injured mouse was right-shifted compared with that
from the sham operated mouse (Figure 1C). The mean
GluA1 density for the nerve injured group (313.2 ± 16.0
particles/μm2, n = 89 synapses/3 mice) was significantly
larger than that for the sham-operated group (243.7 ± 16.4
particles/μm2, n = 86 synapses/3 mice; p <0.01) (Figure 1D).
These results indicate that GluA1 is recruited to the post-
synaptic area in layer V after nerve injury.
Accumulation of postsynaptic GluA1 on spinal cord
projecting neurons in the ACC
In our previous work [15], we found that nerve injury
potentiated AMPAR mediated eEPSCs in the layer V of
the ACC, and this potentiation also occurred on spinal
cord projecting pyramidal cells. We wanted to determine
if GluA1 accumulation also happened on spinal cordinjury. (A-B) SDS-digested freeze fracture replica labeling EM samples
r V neurons in mice with nerve injury compared with mice with sham
ribution of postsynaptic GluA1 density. (D) Averaged density of the
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pose, we injected horseradish peroxidase (HRP) into one
side of the dorsal part of the SC (Figure 2A) and observed
the GluA1 immunogold staining in HRP retrograde label-
ing neurons in the ACC, by exploring pre-embedding
immunostaining transmission electron microscopic (EM)
method. After HRP injection into the dorsal horn of SC,Figure 2 Nerve injury accumulated postsynaptic GluA1 in ACC-SC pro
labeled GluA1 were distributed within the HRP-labeled dendrite and spine
GluA1 particles in 50 nm bins as a function of distance from the nearest ed
synapses. (F-J) Samples and plotted figures showing the distribution of Glu
the VS (F). Bars equal to 1000 μm in (F), 500 μm in (A) and 2 μm in (B, C,HRP retrogradely labeled neurons were mainly found in
layer V of the ACC. Using the electron microscope we
measured the distances between individual gold particles
and the closest edge of postsynaptic active zone of asym-
metric synapses in HRP labeled dendritic profiles and cell
bodies of the layer V neurons. We found that more GluA1
particles were closer to the synaptic active zone injecting neurons. (A-C) Samples showing that immune-gold particles
with HRP injection into the dorsal part of the SC (A). (D) Percentage of
ge of synapses. (E) Averaged distances of GluA1 from the edge of
A1 within the HRP-labeled dendrite and spine with HRP injection into
G, H). ***, p <0.001.
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mals (157.7 ± 3.4 nm, n = 767 particles/135 synapses/3
mice) than those from the sham operated animals (236.1 ±
3.8 nm, n = 751 particles/164 synapses/3 mice. p <0.001)
(Figure 2B-E), suggesting GluA1 was accumulated to post-
synaptic region of the SC projecting neurons in the ACC.
In comparison, we checked whether nerve injury caused
GluA1 accumulation in ACC-ventral striatum (VS) project-
ing neurons, which are more likely to be involved in reward
function [28]. After HRP injection into one side of the VS
(Figure 2F), we found that the HRP retrograde labeled
neurons were also mainly distributed in the layer V of the
ACC. However, the distances between GluA1 immunoreac-
tive gold particles and the closest edge of postsynaptic
active zone of asymmetric synapses in HRP labeled profiles
were not significantly different in mice with nerve injury or
sham operation (nerve injury: 222.5 ± 4.1 nm, n = 719 parti-
cles/158 synapses/3 mice; sham: 231.1 ± 4.1 nm, n = 737
particles/157 synapses/3 mice. p >0.05) (Figure 2G-J). These
findings indicate that nerve injury does not enhance post-
synaptic GluA1 accumulation in the ACC-VS projecting
neurons. In addition, we found that the mean number
of postsynaptic GluA1 immunoparticles was significantly
higher in the SC projecting neurons from nerve injury
group compared with sham operated group (sham sur-
gery: 4.59 ± 0.17, nerve injury: 5.67 ± 0.26, p <0.001). How-
ever, there is no significant difference in the VS projecting
neurons between nerve injury and sham operated group
(sham surgery: 4.70 ± 0.15, nerve injury: 4.57 ± 0.18,
p >0.05). These results strongly suggest that nerve in-
jury induced postsynaptic GluA1 accumulation is select-
ive for SC but not VS projecting neurons in the ACC.
Peak-scaled nonstationary fluctuation analysis
Next, we carried out electrophysiological experiments to
determine if nerve injury increases GluA1 mediated
responses in the layer V of the ACC. The AMPAR medi-
ated eEPSCs on SC or VS projecting neurons in the ACC
were recorded and the peak-scaled nonstationary fluc-
tuation analysis (NSFA) was applied to compare their
AMPAR unitary conductance (γ) and number of active
channels in mice with nerve injury or sham operation
[29,30]. After retrograde tracer DiI injection into one side
of the SC or VS, retrograde labeling pyramidal cells were
recorded using whole- cell patch recording (Figure 3A-B).
AMPAR mediated eEPSCs were induced by stimulating
local fibers in the layer II/III of the ACC (similar as in
[15]). In ACC-SC projecting neurons, we found that the
number of active channels (sham surgery: 92.8 ± 17.4,
nerve injury: 181.4 ± 29.1, p <0.05. n = 10 in each group)
but not the unitary conductance (sham surgery: 17.3 ± 2.0
pS, nerve injury: 18.0 ± 1.5 pS, p >0.05) was increased by
nerve injury (Figure 3C-E). However, in ACC-VS project-
ing neurons, neither the number of active channels (shamsurgery: 109.6 ± 12.6, nerve injury: 111.1 ± 19.2, p >0.05.
n = 7 in each group) nor the unitary conductance (sham
surgery: 17.7 ± 2.0 pS, nerve injury: 18.6 ± 1.7 pS, p >0.05)
was changed (Figure 3F-H). These results strongly suggest
that nerve injury increases the postsynaptic active channels
of AMPAR, as well as the AMPAR mediated responses in
ACC-SC projecting neurons.
AMPAR is heterotetramer of four homologous subunits
(GluA1 to GluA4) that combine in different stoichiome-
tries to form different subunits [25]. GluA2-containing
AMPARs are Ca2+ impermeable and considered to consti-
tutively traffic to postsynaptic regions. During synaptic
potentiation, GluA2 can be replaced by Ca2+ permeable
AMPAR subunits (CP-AMPAR), which are mainly consist
of GluA1 homomers [15,23,31]. We then applied CP-
AMPAR antagonist NASPM on ACC-SC projecting neu-
rons from mice with nerve injury to check whether the
increased channels are predominately of CP-AMPAR. We
found that bath application of NASPM significantly de-
creased the number of active channels to a mean 60.0 ±
6.3% of the baseline (n =8, p <0.01), whereas γ was not af-
fected (101.4 ± 17.3% of baseline, p >0.05) (Figure 3I-K).
NASPM has no effect on ACC-SC projecting neurons
from sham-operated mice (data not shown). These find-
ings are in consistence with the EM results and further
support the notion that nerve injury increased the number
of postsynaptic GluA1 in ACC-SC projecting neurons.Calcium-permeable AMPAR contributes to the LTP in ACC
layer V neurons
From our present and previous results [15], it has been
shown that nerve injury induced the postsynaptic accu-
mulation of GluA1 and potentiated synaptic responses
of the ACC layer V neurons, including those projecting
to the SC. In comparison with mice with sham surgery,
a significant inward rectification of the AMPAR medi-
ated I-V curve were observed in ACC pyramidal cells in
mice with nerve injury, indicating that the GluA2 con-
taining AMPAR were replaced by CP-AMPAR [15].
However, it is difficult to determine the time course of
NASPM produced inhibition using whole-cell patch re-
cording. We next recorded the field excitatory postsyn-
aptic potentials (fEPSPs) in layer V of the ACC using a
Med64 extracellular recording system [32,33]. Similar to
our whole-cell patch-clamp recording results [15], the
slopes of fEPSPs were significantly larger in mice with nerve
injury than that in mice with sham surgery (Figure 4A).
Meanwhile, bath application of NASPM for 30 min
reduced the potentiated fEPSPs in mice with nerve injury,
and the inhibitory effect lasted for at least 5 hrs (66.2 ±
5.4% of the baseline, at 5 hr after NASPM application.
p <0.01, n = 6 slices). However, NASPM had no effect on
the fEPSP recorded from mice with sham surgery (93.6 ±
Figure 3 Nerve injury enhanced the GluA1 channel numbers in ACC-SC projecting neurons. (A-B) Samples showed that DiI retrograde
labeling pyramidal cells in the ACC layer V was dual labeled with biocytin for injection into the SC (A) or VS (B). Bar equal to 20 μm. (C-E) Peak-scaled
nonstationary fluctuation analysis (NSFA) indicated that the AMPAR channel number but not the single channel conductance was increased in ACC-SC
projecting neurons in mice after nerve injury. (F-H) NSFA showed that nerve injury changed neither the AMPAR channel number nor the single
channel conductance in ACC-VS projecting neurons. (I-K) Bath application of CP-AMPAR antagonist NASPM reduces the AMPAR channel number,
without changing the conductance in ACC-SC projecting neurons. *, p <0.05; **, p <0.01.
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p >0.05, n = 6 slices) (Figure 4A).
We then applied theta-burst stimulation (TBS) to induce
a LTP in the layer V neurons in naïve mice and found that
NASPM reversed the potentiated fEPSP slopes. In controlgroup, TBS induced a long-lasting potentiation of synaptic
responses (mean 136.6 ± 10.2% of the baseline at 3 hr;
136.8 ± 8.1% of the baseline at 5 hr; n = 6). In group with
NASPM application, TBS induced potentiation was re-
duced to near baseline level (to 100.8 ± 6.3% of the baseline
Figure 4 NASPM had a long term inhibition on the LTP of ACC layer V neurons. (A) Samples and averaged results showing that bath
application of NASPM (50 μM) for 30 min reduced the slope of fEPSP from layer V neurons in mice with nerve injury but not in mice with sham
surgery. (B) Samples and averaged results showing that TBS induced stable long term potentiation of the fEPSP of layer V neurons. However,
bath application of CP-AMPAR antagonist NASPM for 30 min reversed the LTP effect.
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the increased CP-AMPAR contributes to the potentiated
AMPAR responses.Contribution of CP-AMPARs to nerve injury induced
mechanical hyperalgesia
Does the enhancement and accumulation of CP-AMPAR
within the ACC contribute to injury induced mechanical
hyperalgesia? To address this question, we injected
NASPM into the bilateral ACC (5 nmoles, 0.5 μl per side)
in mice at seven days after nerve injury (Figure 5A). We
found that nerve injury significantly reduced the mechan-
ical withdrawal threshold of adult mice (n = 16 mice,
p <0.001), and that microinjections of NASPM into the
ACC attenuated mechanical hyperalgesia (n = 9 mice,
p <0.001) (Figure 5B), which was persisted for at least 4 hr
and disappeared 12 hr later (Figure 5D). Meanwhile,
NASPM injection into the VS did not affect the mechan-
ical threshold on mice with nerve injury (n = 7 mice,
p >0.05) (Figure 5B), indicating that the ACC is specific
for NASPM’s analgesic effect in neuropathic pain from
adult mice. Finally, NASPM injection into the ACC or VSdid not affect the mechanical threshold in mice with sham
surgery (p >0.05) (Figure 5C).
GluA1 PKA phosphorylation contributed to the
mechanical hyperalgesia
Phosphorylation of GluA1 is important for GluA1 traffick-
ing and synaptic plasticity [24,34]. Previous studies have
shown that nerve injury induced potentiation of ACC layer
V neurons could be blocked in mice with an GluA1 PKA
phosphorylation site serine-845 mutation (s845A) but not
in mice with GluA1 PKC phosphorylation site serine-831
mutation (s831A) [15]. However, it is unknown if PKA
and/or PKC phosphorylation of GluA1 is required for
nerve injury induced mechanical hyperalgesia. Taking ad-
vantage of genetically induced GluA1 phosphorylation site
knockin mice [23], we tested whether GluA1 phosphoryl-
ation was necessary. We found that nerve injury induced
obvious mechanical hyperalgesia in s831A mice (baseline:
0.87 ± 0.11 g, nerve injury: 0.11 ± 0.06 g, n = 6 mice,
p <0.001) (Figure 5E). In contrast, in s845A mice, nerve
injury induced mechanical hyperalgesia were completely
blocked (baseline: 0.74 ± 0.10 g, nerve injury: 0.74 ± 0.14 g,
n = 7 mice, p >0.05) (Figure 5E). These results suggest that
Figure 5 PKA phosphorylation of GluA1 in the ACC was important for the nerve injury induced mechanical hyperalgesia. (A) Diagram
results showed the location of NASPM (filled circle) or saline (open circle) injection sites in the ACC. Bar equals to 200 μm. (B) Nerve injury
induced mechanical hypersensitivity in wild type mice, which can be blocked by injection of NASPM into the ACC but not VS. (C) NASPM
injection into the ACC or VS cannot change the mechanical threshold of mice with sham surgery. (D) NASPM’s effect lasts for at least 4 hrs and
disappeared 12 hrs after injection into the ACC in mice with nerve injury. (E) Summarized behavior results showing that nerve injury induced
mechanical hypersensitivity is absent in s845A but not in s831A mice. (F) Nerve injury induced mechanical hyperalgesia was inhibited by PKA
inhibitor Rp-cAMP consecutive injection into the ACC (before nerve ligation surgery, day 1, day 3, day 5 and day 7 after ligation surgery). #p >0.05,
**p <0.01; ***p <0.001.
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plays important roles in neuropathic pain. Since genetic
manipulation is not specific to the ACC region, we carried
out additional pharmacological experiments to test the role
of PKA in the ACC. The microinjection of a PKA inhibitor
Rp-cAMP (1 nmoles, 0.5 μl per side) into the ACC
produced analgesic effects in mice with nerve injury
(Figure 5F), supporting the important role of ACC PKA
activity in neuropathic pain.
Discussion
In this study, we provide direct evidence that AMPAR
GluA1 subunit is inserted into postsynaptic sites of the
layer V pyramidal cells after peripheral nerve injury. The
newly inserted GluA1 receptors contribute to injury-
induced synaptic LTP in the ACC and behavioral sensi-
tization. There are at least two different mechanisms for
ACC’s contribution to chronic pain. Neurons in the ACC
may play important roles in pain perception [2,8,35], and
enhanced synaptic transmission in the ACC can directly
contribute to chronic pain itself. Second, ACC neurons
may affect spinal pain transmission by its descending
facilitatory modulation [8,36]. Indeed, many deeper layer
ACC pyramidal cells are projecting cells. In a recent study,
we have demonstrated that ACC layer V pyramidal cellsare projected to the dorsal horn of the spinal cord [15]. In
this study, we provide further evidence that postsynaptic
AMPAR GluA1 is increased in spinal projecting ACC
neurons. It is likely that enhanced excitatory transmission
of the spinal projecting ACC neurons may contribute to
increased descending facilitatory modulation in chronic
pain conditions [2,8,36]. Our studies provide strong evi-
dence that inhibiting accumulated GluA1 in the deep layers
of ACC may inhibit sensory pain transmission at the dorsal
horn of the spinal cord. Future in vivo electrophysiological
experiments are needed to confirm this descending modu-
lation of spinal sensory synaptic transmission.
Our previous studies using pharmacological and gen-
etic approaches consistently demonstrate that GluA1 is
critical for ACC LTP [8,16,17]. In the present study, by
taking advantage of the SDS-FRL method, we observed
the morphological characteristic of the postsynaptic area
and confirmed that nerve injury induced GluA1 accu-
mulation in the layer V of the ACC. After peripheral nerve
injury, postsynaptic accumulation of GluA1 receptors me-
diates the LTP of the excitatory synaptic transmission in
the SC projecting ACC neurons. Such potentiation of cor-
ticospinal projections may contribute to the prolonging of
a chronic pain condition. Thus, selective inhibition of the
potentiated ACC-SC neurons may cause a direct analgesic
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ated synaptic transmission could be observed in the ACC
after nerve injury and TBS induced LTP is occluded in
animal model of neuropathic pain [15,30], our results also
provide possible explanation for the occlusion of LTP in
chronic pain conditions: the recruitment of GluA1 into
synapses prevents any further AMPAR insertion triggered
by LTP induction protocol.
In addition to in vitro electrophysiological experiments in
the present study and in previous works [15], we performed
pharmacological experiments to determine if inhibition of
ACC LTP by microinjection of NASPM into the ACC pro-
duced inhibitory effects in mechanical hyperalgesia caused
by nerve injury. As expected, bilateral microinjections of
NASPM into the ACC produced significant analgesic ef-
fects in adult mice with nerve injury. This finding provides
a novel strategy for chronic pain treatment - inhibiting the
potentiated activity of corticospinal projecting neurons may
produce a direct analgesic effect. Previous studies revealed
the descending pain facilitation system may rely on brain-
stem rostral ventromedial medulla (RVM) cells, and seroto-
nergic projection from RVM-spinal cord is likely play key
roles for the descending facilitation [37-40]. The present
study provides a new cortical-spinal projecting pathway
that may not require the involvement of RVM. Our prelim-
inary in vivo whole-cell patch-clamp studies show that
stimulation of the ACC directly potentiated the activity of
spinal cord neurons (Chen et al., unpublished data). Con-
sidering glutamate is the major transmitter for most of the
pyramidal cells in the ACC, it also raises the possibility that
glutamate may act as a transmitter for descending pain
modulation in the spinal cord. Different types of glutamate
receptors in the spinal cord, such as NMDA, AMPA, kai-
nate and metabotropic glutamate receptors may acts as
possible candidates for the amplified excitation in the spinal
cord [41-43]. Future studies are needed to reveal the exact
synaptic mechanisms.
In a previous study, we observed, through western blot
analysis, that nerve injury increases phosphorylated-GluA1
expression in layer II/III neuronal membrane in the ACC
[11]. However, it is unknown if this PKA phosphorylation
is actually required for behavioral hyperalgesia. Through
the use of mice with PKC or PKA phosphorylation site
mutations, we showed that PKA phosphorylated site ser-
845 but not PKC phosphorylated site ser-831 on GluA1 is
necessary for neuropathic pain processes. This finding is
consistent with previous works in the ACC that show the
requirement of adenylyl cyclase type 1 (AC1)-cAMP sig-
naling pathway for the induction of ACC LTP: ACC LTP is
blocked in gene knockout mice lacking AC1 [44], and a
selective AC1 inhibitor NB001 prevented the induction of
LTP [45]. In addition, we have to point out that the mutant
mice we used are not regionally specific for ACC. Thus, we
cannot rule out the possible compensation or contributionof other brain areas to behavioral efforts we found. How-
ever, the analgesic effect that arises from PKA inhibition in
the ACC can, at least partially, confirm the importance of
PKA phosphorylation for the development of mechanical
hyperalgesia.
The present study provides strong evidence for the LTP
effect in layer V pyramidal cells in the ACC in chronic
neuropathic pain conditions. At the synaptic level, this is
the first study to show that AMPARs GluA1 postsynaptic
accumulation mediates the nerve injury-induced LTP in
the ACC output neurons, especially those projecting to
the spinal cord. At circuit level, our results suggest that
potentiated synaptic responses may increase intrinsic ex-
citability of the corticospinal projecting neurons and sub-
sequently trigger spinal facilitation. In case of nerve injury,
this ACC-spinal cord loop is activated and contributes to
the maintenance of hyperalgesia. These findings thus pro-
vide new methods and targets for chronic pain treatment.
One may reduce chronic pain by inhibiting injury trig-
gered potentiation in the cortex and/or inhibiting de-
scending facilitation by corticospinal projections from the
ACC. Future studies are clearly needed to identify the
transmitters and mechanisms for such cortico-spinal de-
scending facilitation in different chronic pain conditions.Methods
Animals
Adult male C57BL/6, GluA1 serine-831 and serine-845
phosphorylation site mutant (s831A and s845A) mice
were used. Animals were randomly housed under a 12-h
light–dark cycle (9 a.m. to 9 p.m. light), with food and
water freely available, at least one week before carrying out
experiments. All procedures involving animals were under
the guidelines of the Fourth Military Medical University,
Xi’an Jiaotong University, University of Toronto, Johns
Hopkins University and National Institute for Physiological
Sciences Animal Care and Use Committee.Nerve injury model
A model of neuropathic pain was induced by the ligation
of the common peroneal nerve (CPN) as described previ-
ously [11,30,46]. Briefly, mice were anesthetized by an
intraperitoneal injection of a mixture saline of ketamine
(0.16 mg/kg) and xylazine (0.01 mg/kg). The CPN was vis-
ible between the anterior and posterior groups of muscles,
running almost transversely. The left CPN was slowly
ligated with chromic gut suture 5–0 until contraction of
the dorsiflexor of the foot was visible as twitching of the
digits. The skin was then sutured and cleaned. Sham
surgery was conducted in the same manner, but the nerve
was not ligated. The mice were used for behavior and/or
electrophysiological studies on postsurgical days 7.
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Cannulation and microinjection were performed as de-
scribed previously [30]. After anesthesia, the head of the
mouse was fixed on a stereotaxic frame and the scalp was
shaved and then cleaned with povidone-iodine and alco-
hol. An incision was made over the skull and the surface
was exposed. Two small holes were drilled above the ACC
and guide cannulas were placed so that the final coordi-
nates for microinjection would be 0.7 mm anterior to the
bregma, 0.3 mm lateral to the midline, and 1.75 mm
ventral to the surface of the skull for the ACC, according
to the atlas of Paxinos and Watson (1999). For microinjec-
tion, the mice were restrained in a plastic cone and a small
hole over the guide cannulas was made. A 30-gauge
injector 0.7 mm lower than the guide was used. The
microinjection was conducted using a motorized syringe
pump (Razel Scientific Instruments, CT, USA) and a
Hamilton microsyringe (Hamilton, Reno, NY, USA). Pure
saline (0.9%), NASPM (5 μM), AP5 (50 μM) or Rp-cAMP
(2 μM) dissolved in saline was delivered bilaterally into
the ACC (0.5 μl/side, total 1 μl). The injector was left in
place for 1 min.
Behavior observation
One week following nerve ligation or sham surgery, mice
paw withdrawal threshold was tested with von Frey fila-
ments applied to the paw [47]. The animals were placed
in Lucite cubicles over a wire mesh and acclimated for
30 min before testing. A series of filaments (0.008, 0.02,
0.04, 0.16, 0.4, 0.6, 1, 1.4, 2 g) with various bending
forces (according to 0.078, 0.196, 0.392, 1.568, 3.92, 5.88,
9.8, 13.72, 19.6 mN) were applied to the plantar surface
of the hindpaw ipsilateral to the nerve injury side until
the mice withdrew from the stimulus. Each filament was
applied twice. The lowest force at which a withdrawal
response was obtained was taken as the paw withdrawal
threshold.
SDS digested freeze-fracture replica labeling
Animals were perfused with 0.1 M PB (pH 7.4) which con-
tained 2% paraformaldehyde and 15% picric acid. Blocks
containing the ACC were cut into 150 μm-thick sections
with a microslicer (Leica Microsystems VT1000s). After
ACC layer V regions were trimmed out (about 0.5 mm2),
they were cryprotected with 10%, 20% glycerol in
0.1 M PB for 30 min, and 30% glycerol in 0.1 M PB over-
night at 4°C and then frozen with a high-pressure freezing
machine (HPM 010; Bal-Tec, Balzers, Liechtenstein). The
frozen sections were fractured in a freeze-etching device
(BAF 060; Bal-Tec) and the fractured faces were first repli-
cated by deposition of carbon (5 nm, rotating) with an
electron beam gun positioned at a 450 angle, shadowing
unidirectionally by platinum (2 nm) with the gun po-
sitioned at a 600 angle, followed by carbon (15 nm)evaporated from a 450 angle. Tissue debris attached to
replicas were dissolved with a solution containing 2.5%
SDS and 20% sucrose made up in 15 mM Tris buffer
(pH 8.3) under gentle shaking at 80°C for 18 hours. Rep-
licas were then washed in 25 mM TBS containing 0.05%
BSA three times and incubated in a blocking solution
containing 5% BSA in 25 mM TBS for 1 h. Subsequently,
the replicas were incubated in a purified anti-c terminal of
GluA1 antibody (1:1000, kindly provided by Dr. Makoto
Itakura diluted in 25 mM TBS containing 1% BSA for
36 hours at 4°C. After several washes, the replicas were
incubated in goat anti-rabbit IgG coupled to 5 nm gold
particles (1:30; BioCell Research Laboratories) diluted in
25 mM TBS containing 5% BSA overnight at 4°C. After
washing in 25 mM TBS containing 0.05% BSA three times
and double distilled water once, the replicas were picked
up on 100-line copper grids and analyzed under a Tec-
nai12 electron microscope (Philips, Netherlands).
Clusters of intramembrane particles (IMP) on the exo-
plasmic fracture-face (E-face) were taken as excitatory
postsynaptic specialization [48]. IMP clusters were defined
as packed IMPs with less than 15 nm distance from each
other. Here, we considered an IMP cluster as postsynaptic
membrane specialization if the cluster contained at least
30 IMPs. Immunogold particles were regarded as associ-
ated with the postsynaptic membrane specialization if they
were above or in the immediate vicinity (not further than
20 nm from the edge) of the IMP cluster. The outline of
synaptic sites was demarcated freehand, and areas of IMP
clusters were measured with Image J software. Immuno-
particles within the demarcated IMP cluster were counted
manually. The density of immunoparticles for GluA1 was
calculated by dividing the number of immunoparticles by
the area of IMP cluster.
HRP retrograde labeling and pre-embedding EM methods
The procedure for retrograde tracer WGA-HRP injection
into the spinal cord (SC) or ventral striatum (VS) was
according to our previous works [49,50]. The anesthetic
mice were fixed on a stereotaxic frame. For the SC injec-
tion, the skin between scapulas was incised and paraver-
tebral muscles were cut off and vertebral plate of the
fourth cervical vertebra was exposed. The vertebral plate
was removed and the intumescentia cervialis was exposed.
For VS injection, the skull was exposed, and a hole was
drilled through the skull over the VS (0.38 mm anterior to
bregma, 2.0 mm lateral to the midline and 4.5 mm ventral
to the surface of the skull for the VS). Then 0.4 μl WGA-
HRP (40 mg/ml, Vector Laboratories, Burlingame, U.S.A.)
was injected into one side of the SC or VS. Brain samples
were sliced for pre-embedding immunostainning after
72 hrs. Sections were processed for the histochemical
demonstration of WGA-HRP by using the tetramethy-
lbenzidine-sodium tungstate (TMB-ST) method and the
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H2O2 solution. After histochemical confirmation of HRP
reactive product, the sections were washed several times in
0.1 M PB. Sections were cryoprotected in solutions
containing a mixture of 30% (w/v) sucrose and 10% (v/v)
glycerol in 0.05 M PB for 30 min. The sections were freeze-
thawed with liquid nitrogen and then incubated in a block-
ing solution containing 20% normal goat serum (NGS) in
0.05 M Tris-buffered saline (TBS; pH 7.4) for 30 min to
block the non-specific immunoreactivity, followed by incu-
bation with rabbit anti-GluA1 antibody (1:600) at 4°C for
12 hrs. After washing in TBS, the sections were incubated
for 8 hours in 1:100-diluted anti-rabbit antibody conjugated
to 1.4 nm gold particles (Nanoprobes; Stony Brook, NY,
U.S.A). The sections were then processed as follows: (1) 1%
postfixation with glutaraldehyde in 0.1 M PB for 10 min;
(2) silver enhancement with an HQ Silver Kit (Nanoprobes,
Stony Brook, NY, U.S.A). The sections were then treated
with 1% OsO4 in 0.1 M PB for 1 hr. Subsequently, the sec-
tions were counterstained with 1% (w/v) uranyl acetate in
70% ethanol for 1 hr. After dehydration, the sections were
mounted on silicon-coated glass slides and flat embedded
in epoxy resin (Durcupan; Fluka, Buchs, Switzerland).
Under electron microscope, HRP-labeled neurons were de-
tected by the presence of highly electron-dense clumps of
crystalline material and sometimes by amorphous punctual
structures in the cytoplasm of the dendrites and somata.
GluA1 immunoreactivity was determined by the presence
of the immunogold-silver particles which were distributed
in the cytoplasm of the somata and dendrites. Asymmetric
synaptic junction containing more than 3 immunogold-
silver grain particles were considered as GluA1-immu-
noreactive postsynaptic structure.
Extracellular field EPSP recording
The MED64 probe (P515A, Panasonic, Japan) has an
array of 64 planar microelectrodes, arranged in an 8 × 8
pattern, with an interpolar distance of 150 μm. Before
use, the surface of the MED64 probe was treated with
0.1% polyethyleneimine (Sigma, St. Louis, MO; P-3143)
in 25 mmol/L borate buffer (pH 8.4) overnight at room
temperature. Then the probe surface was rinsed three
times with sterile distilled water [32,33]. Acute coronal
brain slices (300 μm) containing the ACC, were pre-
pared using standard methods [11,30,51]. After 1 hr for
recovery in standard ACSF, slices were transferred to the
recording chamber and subfused with ACSF at 28-30°C
and maintained at a 2 ml/min flow rate. The slices were
positioned on the MED64 probe in such a way that the
middle part of the probe close to the central point of the
ACC. One of the channels located in the superficial
layers (II-III) of the ACC, from which the best synaptic
responses can be induced in the surrounding channels
in deep layers (V), was chosen as the stimulation site.Slices were kept in the recording chamber for at least
1 hr before the start of experiments. Bipolar constant
current pulse stimulation (1–10 μA, 0.2 ms) was applied
to the stimulation channel and the intensity was ad-
justed so that a half-maximal field excitatory postsynap-
tic potential (fEPSP) was elicited in the channels closest
to the stimulation site. The fEPSP responses were sam-
pled every 1 min and averaged every 4 min. The param-
eter of “slope” indicated the averaged slope of each
fEPSP recorded by activated channels. Stable baseline
responses were first recorded until the baseline response
variation is less than 5% in most of the active channels
within 1 hr. In some cases, a theta-burst stimulation
(TBS, five trains of bursts with four pulses at 100 Hz, at
200 ms interval; repeated five times at intervals of 10 s)
was applied to the stimulation channel to induce L-LTP.
Whole-cell patch-clamp recordings on retrograde labeling
ACC neurons
0.25% DiI distilled in saline solution was unilaterally
pressure-injected (1 μl) into the C4-5 SC (in the same
time with CPN ligation or sham surgery) or VS (4 days
after CPN ligation or sham surgery) with a Hamilton
microsyringe attached with a glass micropipette (tip outer
diameters ranged from 10–20 μm). Those mice were
allowed to survive for 3–7 days before whole cell patch
experimental procedures. Then mice were sacrificed and
coronal brain slices (300 μm) at the level of the ACC were
prepared using standard methods. Slices were transferred
to a submerged recovery chamber containing oxygenated
(95% O2 and 5% CO2) ACSF (124 mM NaCl, 4.4 mM
KCl, 2 mM CaCl2, 1 mM MgSO4, 25 mM NaHCO3,
1 mM NaH2PO4, and 10 mM glucose) at room tempe-
rature for at least 1 hr and then heated up to 32°C for
recording. Evoked EPSCs were recorded from layer V neu-
rons in randomly selected sides of the ACC, with an Axon
200B amplifier, and stimulations were delivered by a bipo-
lar tungsten stimulating electrode placed in layer II/III of
the ACC. AMPAR-mediated EPSCs were induced by
repetitive stimulations at 0.02 Hz, and neurons were
voltage-clamped at −60 mV in the presence of AP5
(50 μM) and picrotoxin (100 μM). The recording pipettes
(3–5 MΩ) were filled with a solution containing (in mM)
112 Cs-Gluconate, 5 TEA-Cl, 3.7 NaCl, 0.2 EGTA, 10
HEPES, 2 MgATP, 0.3 Na3GTP and 5 QX-314 (adjusted
to PH 7.2 with CsOH, 290 mOsmol). The initial access re-
sistance was 15–30 MΩ, and it was monitored throughout
the experiment. Data were discarded if the access resist-
ance changed >15% during experiment. Data were filtered
at 1 kHz, and digitized at 10 kHz.
Retrograde labeling cells were observed under FV-
1000 confocal microscope under proper filters for DiI
(excitation 549 nm; emission 565 nm). In some cases,
biocytin (0.5%) was distilled into the recording pipette
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After recording, the slices with biocytin labeled neurons
were fixed with 4% paraformaldehyde in 0.1 M PB
(pH 7.4) for 2 hrs at room temperature. Then the slices
were immunostained with Alexa-594 conjugated avidin
(1:200), thoroughly washed and observed under FV-1000
confocal microscope for DiI and Alexa-594 labeled
neurons by using standard method.
NSFA
Nonstationary peak-scaled fluctuation analysis (NSFA)
[30,52] was performed on the AMPAR mediated eEPSC
using Mini Analysis Program 6.0.3. The eEPSCs were
recorded on ACC-SC or ACC-VS projecting neurons in
layer V of the ACC and induced by applying a constant
intensity (8 V) in layer II/III. After a stable baseline
recording for 10 min, NASPM was bath applied for an-
other 20 min and data were collected for analysis. When
doing NSFA, the eEPSCs were aligned on the rising
phase at the half-maximal amplitude and averaged. The
variance of the individual trace v. s. the averaged trace at
decay phase was calculated and plotted against the bin
amplitude of the averaged response. The collected data
were fitted with the following parabolic function using a
least-squares algorithm:




Where the Np was the number of active channels,
which was defined as number of physical channels ×
open probability. I is the bin value, σ2 is the variance, σb
2
indicates the variances of background.
The unit conductance was calculated as:
γ ¼ i= Vh‐Vrevð Þ
Vh indicates the holding potential, Vrev indicated the
reversal membrane potential of the eEPSC (about 0 mV)
[53].
Statistical analyses
All experiments were carried out as blind to genotype
and the conditions of the experiments, unless indicated
in naïve animals. Data were collected and processed ran-
domly, and no data points were excluded. No statistical
methods were used to predetermine sample sizes, but
our sample sizes were similar to those reported in previ-
ous publications. Statistical comparisons were made
using the unpaired, paired t-test or two-way ANOVA
(Tukey test was used for post hoc comparison). The nor-
mal distribution and the variation within each group of
data were verified by using Sigmaplot 11.0 software be-
fore applying statistical comparison. Analyzed numbers
(n) for each set of experiments are indicated in thecorresponding figure legends or main text sections. The
examples shown in each figure are representative and
were reproducible at least three times for each set of
experiments. All data were presented as the Mean ± S.E.
M. In all cases, p <0.05 was considered statistically
significant.
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